Unlock stock picks and a broker-level newsfeed that powers Wall Street.
Upgrade Now
NasdaqCM - Delayed Quote USD

Aldeyra Therapeutics, Inc. (ALDX)

Compare
5.32
-0.15
(-2.74%)
At close: 4:00:01 PM EDT
5.01
-0.31
(-5.92%)
After hours: 5:33:51 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Expense
60,117.03
60,117.03
42,794.08
62,679.99
56,219.54
Operating Income
-60,117.03
-60,117.03
-42,794.08
-62,679.99
-56,219.54
Net Non Operating Interest Income Expense
4,265.59
4,265.59
5,251.57
655.35
-1,556.74
Pretax Income
-55,851.44
-55,851.44
-37,542.51
-62,024.64
-57,776.27
Net Income Common Stockholders
-55,851.44
-55,851.44
-37,542.51
-62,024.64
-57,776.27
Diluted NI Available to Com Stockholders
-55,851.44
-55,851.44
-37,542.51
-62,024.64
-57,776.27
Basic EPS
-0.75
-0.94
-0.64
-1.06
-1.07
Diluted EPS
-0.75
-0.94
-0.64
-1.06
-1.07
Basic Average Shares
59,389.22
59,484.79
58,943.21
58,405.90
54,042.10
Diluted Average Shares
59,389.22
59,484.79
58,943.21
58,405.90
54,042.10
Total Operating Income as Reported
-60,117.03
-60,117.03
-42,794.08
-62,679.99
-56,219.54
Total Expenses
60,117.03
60,117.03
42,794.08
62,679.99
56,219.54
Net Income from Continuing & Discontinued Operation
-55,851.44
-55,851.44
-37,542.51
-62,024.64
-57,776.27
Normalized Income
-55,851.44
-55,851.44
-37,542.51
-62,024.64
-57,776.27
Interest Income
6,191.83
6,191.83
7,323.01
2,349.45
185.36
Interest Expense
1,926.24
1,926.24
2,071.44
1,694.10
1,742.10
Net Interest Income
4,265.59
4,265.59
5,251.57
655.35
-1,556.74
EBIT
-53,925.20
-53,925.20
-35,471.08
-60,330.54
-56,034.17
EBITDA
-53,675.58
-53,675.58
-35,208.30
-60,071.83
-55,769.99
Reconciled Depreciation
249.62
249.62
262.78
258.71
264.18
Net Income from Continuing Operation Net Minority Interest
-55,851.44
-55,851.44
-37,542.51
-62,024.64
-57,776.27
Normalized EBITDA
-53,675.58
-53,675.58
-35,208.30
-60,071.83
-55,769.99
12/31/2021 - 5/2/2014

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

ABEO Abeona Therapeutics Inc.
4.6800
+5.17%
 
MIST Milestone Pharmaceuticals Inc.
0.8031
+5.67%
 
ATRA Atara Biotherapeutics, Inc.
6.13
+2.00%
 
CAPR Capricor Therapeutics, Inc.
9.74
+2.80%
 
ARDX Ardelyx, Inc.
4.8800
+1.88%
 
THTX Theratechnologies Inc.
1.4700
+5.00%
 
SCPH scPharmaceuticals Inc.
2.5000
+7.30%
 
KALV KalVista Pharmaceuticals, Inc.
11.09
-0.58%
 
ANVS Annovis Bio, Inc.
1.5900
+6.71%
 
URGN UroGen Pharma Ltd.
11.20
+5.36%